CVS Health Corporation $CVS Shares Acquired by Patrick Mauro Investment Advisor INC.

Patrick Mauro Investment Advisor INC. increased its position in shares of CVS Health Corporation (NYSE:CVS) by 4.5% during the second quarter, Holdings Channel.com reports. The fund owned 60,264 shares of the pharmacy operator’s stock after acquiring an additional 2,622 shares during the quarter. CVS Health accounts for approximately 2.2% of Patrick Mauro Investment Advisor INC.’s investment portfolio, making the stock its 20th largest position. Patrick Mauro Investment Advisor INC.’s holdings in CVS Health were worth $3,947,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of CVS. FineMark National Bank & Trust grew its stake in shares of CVS Health by 1.7% in the 2nd quarter. FineMark National Bank & Trust now owns 9,576 shares of the pharmacy operator’s stock worth $661,000 after purchasing an additional 157 shares during the last quarter. Hazlett Burt & Watson Inc. grew its position in CVS Health by 10.9% in the second quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock worth $117,000 after buying an additional 165 shares during the last quarter. Williams Financial LLC increased its holdings in shares of CVS Health by 2.5% in the second quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock valued at $478,000 after buying an additional 167 shares in the last quarter. Hemington Wealth Management lifted its position in shares of CVS Health by 33.7% during the 1st quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock valued at $46,000 after acquiring an additional 172 shares during the last quarter. Finally, Sunpointe LLC lifted its position in shares of CVS Health by 4.0% during the 2nd quarter. Sunpointe LLC now owns 4,760 shares of the pharmacy operator’s stock valued at $328,000 after acquiring an additional 185 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Up 2.5%

CVS Health stock opened at $77.92 on Friday. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The company’s fifty day simple moving average is $78.12 and its 200-day simple moving average is $70.28. The stock has a market cap of $98.91 billion, a P/E ratio of 205.06, a P/E/G ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same quarter in the previous year, the company posted $1.09 earnings per share. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. CVS Health’s dividend payout ratio is currently 700.00%.

Analyst Ratings Changes

CVS has been the topic of a number of recent analyst reports. Barclays boosted their target price on CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Leerink Partners boosted their price objective on CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 16th. Zacks Research cut shares of CVS Health from a “strong-buy” rating to a “hold” rating in a report on Monday, September 8th. Truist Financial restated a “buy” rating and set a $95.00 price target (up previously from $92.00) on shares of CVS Health in a report on Thursday, October 30th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Monday, November 17th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $89.41.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.